US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Jupiter Neurosciences

0.5199

-0.0370-6.64%

Post-market: 0.51990.00000.00%19:48 EST

Volume:31.88K

Turnover:17.09K

Market Cap:17.90M

PE:-2.26

High:0.5665

Open:0.5556

Low:0.5103

Close:0.5569

52wk High:3.33

52wk Low:0.4800

Shares:34.43M

Float Shares:14.88M

Volume Ratio:0.71

T/O Rate:0.21%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.2303

EPS(LYR):-0.0848

ROE:--

ROA:-354.94%

PB:311.72

PE(LYR):-6.13

Loading ...

Overview Company News Filings

Jupiter Neurosciences Amends Yorkville Financing Agreement Terms

Jupiter Neurosciences Amends Yorkville Convertible Notes to Delay Monthly Payments Until April 2026

Jupiter Neurosciences Inc - Announces Strategic Initiative for Glp-1 Users

THOMSON REUTERS

Jupiter Neurosciences Expands Nugevia™ Addressable Market with Focus on GLP-1 Users

Jupiter Neurosciences to Present at DealFlow Discovery Conference in Atlantic City

Jupiter Neurosciences Secures $1.86 Million Second Tranche Financing from Yorkville

Jupiter Neurosciences Inc. Held Annual Shareholder Meeting

Jupiter Neurosciences to Present at NobleCon21 Emerging Growth Conference

BRIEF-Jupiter Neurosciences Files Rospectus Related To Resale Of Up To 10 Million Shares Of Our Common Stock By Selling Stockholder

Jupiter Neurosciences Inc - Files Rospectus Related to Resale of up to 10 Mln Shares of Our Common Stock by Selling Stockholder

THOMSON REUTERS

Jupiter Neurosciences Issues Amended SEC Filing

Jupiter Neurosciences price target lowered to $25 from $30 at Greenridge

Jupiter receives FDA clearance of IND application to initiate Phase 2 trial

BRIEF-Jupiter Neurosciences Receives FDA Clearance of IND Application to Initiate Phase 2a Clinical Trial of JOTROL in Parkinson’s Disease

Jupiter Neurosciences Inc - Expects Trial Enrollment to Begin in Early 2026

THOMSON REUTERS

Jupiter Neurosciences Inc - Proceeds to Support Phase 2 Parkinson's Trial and Nugevia Growth

THOMSON REUTERS

Jupiter Neurosciences Enters into Agreements for up to $20 Million in Flexible Financing

Jupiter Neurosciences Inc. Announces Date for Upcoming Annual Stockholders Meeting

Jupiter Neurosciences Names Visionary Entrepreneur and Biohacker Jean Fallacara as Third Nugevia™ Brand Ambassador

Jupiter Neurosciences Launches Nugevia™ Website and Opens Pre-Orders for Groundbreaking Longevity Supplements

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/JUNS/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"JUNS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"JUNS\",,,,,undefined,":{"symbol":"JUNS","market":"US","secType":"STK","nameCN":"Jupiter Neurosciences","latestPrice":0.5199,"timestamp":1771621200000,"preClose":0.5569,"halted":0,"volume":31876,"hourTrading":{"tag":"盘后","latestPrice":0.5199,"preClose":0.5199,"latestTime":"19:48 EST","volume":242,"amount":125.799,"timestamp":1771634937647,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.06643921709463085,"floatShares":14876300,"shares":34426355,"eps":-0.230265,"marketStatus":"Market Closed","change":-0.037,"latestTime":"02-20 16:00:00 EST","open":0.5556,"high":0.5665,"low":0.5103,"amount":17088.304749360002,"amplitude":0.100916,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.230265,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1771837200000},"marketStatusCode":7,"adr":0,"listingDate":1733202000000,"exchange":"NASDAQ","adjPreClose":0.5569,"preHourTrading":{"tag":"盘前","latestPrice":0.5569,"preClose":0.5569,"latestTime":"08:00 EST","volume":763,"amount":424.95610038,"timestamp":1771592404999,"change":0,"changeRate":0,"amplitude":0.00018},"postHourTrading":{"tag":"盘后","latestPrice":0.5199,"preClose":0.5199,"latestTime":"19:48 EST","volume":242,"amount":125.799,"timestamp":1771634937647,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.7087515137456156},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"JUNS\",,,,,undefined,":{"symbol":"JUNS","floatShares":14876300,"roa":"-354.94%","roe":"--","lyrEps":-0.084759,"volumeRatio":0.7087515137456156,"shares":34426355,"dividePrice":0,"high":0.5665,"amplitude":0.100916,"preClose":0.5569,"low":0.5103,"week52Low":0.48,"pbRate":"311.72","psRate":"76.72","week52High":3.33,"institutionHeld":0,"latestPrice":0.5199,"eps":-0.230265,"divideRate":0,"volume":31876,"delay":0,"ttmEps":-0.230265,"open":0.5556,"prevYearClose":1.02,"prevWeekClose":0.5779,"prevMonthClose":0.5278,"prevQuarterClose":1.02,"fiveDayClose":0.579,"twentyDayClose":0.935,"sixtyDayClose":1.18},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/JUNS\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"JUNS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"JUNS\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1734670800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/JUNS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"JUNS","date":"2026-02-20","current":-2.257833,"percent":0.993355,"low":-282.025188,"twenty":-18.599351,"median":-8.973217,"eighty":-5.552986,"high":-2.391609,"avg":-27.658326,"sd":54.73825,"marketCap":19172037},"quantilePoints":[{"date":"2022-09-20","current":-11.989719,"twenty":-11.989719,"median":-11.989719,"eighty":-11.989719,"marketCap":56920086},{"date":"2024-12-06","current":-79.299938,"twenty":-65.837894,"median":-45.644828,"eighty":-25.451763,"marketCap":200217355},{"date":"2024-12-13","current":-200.137938,"twenty":-144.536832,"median":-104.691543,"eighty":-83.727192,"marketCap":505310467},{"date":"2024-12-20","current":-141.411712,"twenty":-153.808024,"median":-137.570417,"eighty":-102.087276,"marketCap":357037845},{"date":"2024-12-27","current":-282.025188,"twenty":-200.137938,"median":-143.885765,"eighty":-104.691543,"marketCap":378377119},{"date":"2025-01-03","current":-258.831516,"twenty":-265.592225,"median":-152.284527,"eighty":-119.900464,"marketCap":347259491},{"date":"2025-01-10","current":-213.431136,"twenty":-260.904142,"median":-179.564226,"eighty":-125.499639,"marketCap":286348389},{"date":"2025-01-17","current":-105.358491,"twenty":-256.166711,"median":-158.990515,"eighty":-125.499639,"marketCap":141353482},{"date":"2025-01-24","current":-35.777474,"twenty":-238.993524,"median":-149.745367,"eighty":-106.641545,"marketCap":48000597},{"date":"2025-01-31","current":-27.635014,"twenty":-214.911583,"median":-143.885765,"eighty":-82.913302,"marketCap":37076323},{"date":"2025-02-07","current":-25.167602,"twenty":-213.431136,"median":-133.729123,"eighty":-31.089391,"marketCap":33765937},{"date":"2025-02-14","current":-20.913783,"twenty":-212.444171,"median":-125.200148,"eighty":-25.907825,"marketCap":28058831},{"date":"2025-02-21","current":-20.64977,"twenty":-210.716983,"median":-106.962309,"eighty":-24.176689,"marketCap":27704620},{"date":"2025-02-28","current":-16.506986,"twenty":-208.84175,"median":-101.436209,"eighty":-21.463029,"marketCap":22146482},{"date":"2025-03-07","current":-16.284919,"twenty":-204.258528,"median":-57.538706,"eighty":-20.655198,"marketCap":21848547},{"date":"2025-03-14","current":-15.006799,"twenty":-191.908453,"median":-32.569838,"eighty":-17.607452,"marketCap":20133767},{"date":"2025-03-21","current":-19.196465,"twenty":-158.15715,"median":-28.621979,"eighty":-16.511921,"marketCap":25754803},{"date":"2025-03-28","current":-18.327936,"twenty":-153.808024,"median":-25.414343,"eighty":-16.605682,"marketCap":24589547},{"date":"2025-04-04","current":-8.521483,"twenty":-149.207844,"median":-24.548282,"eighty":-16.107265,"marketCap":20789224},{"date":"2025-04-11","current":-7.449513,"twenty":-146.918166,"median":-22.108011,"eighty":-15.634508,"marketCap":18174019},{"date":"2025-04-17","current":-9.589382,"twenty":-146.359819,"median":-21.385059,"eighty":-15.098093,"marketCap":23394497},{"date":"2025-04-25","current":-8.912278,"twenty":-141.411712,"median":-20.795347,"eighty":-11.989719,"marketCap":21742615},{"date":"2025-05-02","current":-8.581188,"twenty":-133.733729,"median":-20.647303,"eighty":-9.091392,"marketCap":20934881},{"date":"2025-05-09","current":-8.478062,"twenty":-133.729123,"median":-19.122442,"eighty":-8.684314,"marketCap":20683291},{"date":"2025-05-16","current":-8.182252,"twenty":-133.240246,"median":-18.480916,"eighty":-8.651748,"marketCap":19961627},{"date":"2025-05-23","current":-5.649035,"twenty":-126.697602,"median":-18.135478,"eighty":-8.48756,"marketCap":18836096},{"date":"2025-05-30","current":-8.360373,"twenty":-124.301676,"median":-17.074491,"eighty":-8.4189,"marketCap":27876760},{"date":"2025-06-06","current":-8.223366,"twenty":-111.59344,"median":-16.506986,"eighty":-8.349173,"marketCap":27419927},{"date":"2025-06-13","current":-11.119365,"twenty":-106.000018,"median":-16.356473,"eighty":-8.349173,"marketCap":37076323},{"date":"2025-06-20","current":-12.310726,"twenty":-104.958322,"median":-15.976491,"eighty":-8.391907,"marketCap":41048786},{"date":"2025-06-27","current":-10.722245,"twenty":-102.738343,"median":-15.697674,"eighty":-8.414557,"marketCap":35752168},{"date":"2025-07-03","current":-16.381208,"twenty":-96.195065,"median":-15.618717,"eighty":-8.417271,"marketCap":54621369},{"date":"2025-07-11","current":-18.962489,"twenty":-84.719984,"median":-15.658195,"eighty":-8.425762,"marketCap":63228372},{"date":"2025-07-18","current":-17.076168,"twenty":-61.890952,"median":-15.890132,"eighty":-8.436927,"marketCap":56938639},{"date":"2025-07-25","current":-16.579768,"twenty":-35.382688,"median":-16.07311,"eighty":-8.455266,"marketCap":55283446},{"date":"2025-08-01","current":-13.899207,"twenty":-33.90224,"median":-15.984088,"eighty":-8.481861,"marketCap":46345404},{"date":"2025-08-08","current":-12.707846,"twenty":-31.582873,"median":-15.769229,"eighty":-8.501129,"marketCap":42372940},{"date":"2025-08-15","current":-13.303526,"twenty":-29.905033,"median":-15.618717,"eighty":-8.545365,"marketCap":44359172},{"date":"2025-08-22","current":-8.737079,"twenty":-29.559836,"median":-15.189388,"eighty":-8.501129,"marketCap":51552962},{"date":"2025-08-29","current":-8.619011,"twenty":-28.850782,"median":-14.892007,"eighty":-8.509158,"marketCap":50856301},{"date":"2025-09-05","current":-7.37929,"twenty":-27.845157,"median":-14.594167,"eighty":-8.479962,"marketCap":43541353},{"date":"2025-09-12","current":-9.209354,"twenty":-27.437621,"median":-14.247558,"eighty":-8.43588,"marketCap":54339609},{"date":"2025-09-19","current":-8.441908,"twenty":-26.401308,"median":-13.899207,"eighty":-8.440436,"marketCap":49811308},{"date":"2025-09-26","current":-8.264805,"twenty":-25.364995,"median":-13.402806,"eighty":-8.416457,"marketCap":48766316},{"date":"2025-10-03","current":-10.153903,"twenty":-25.167602,"median":-12.707846,"eighty":-8.422738,"marketCap":59912902},{"date":"2025-10-10","current":-9.504526,"twenty":-24.919874,"median":-12.211446,"eighty":-8.43588,"marketCap":56081263},{"date":"2025-10-17","current":-9.622594,"twenty":-23.690195,"median":-11.989719,"eighty":-8.440436,"marketCap":56777925},{"date":"2025-10-24","current":-8.737079,"twenty":-22.668925,"median":-11.317926,"eighty":-8.441908,"marketCap":51552962},{"date":"2025-10-31","current":-8.401057,"twenty":-22.344882,"median":-11.119365,"eighty":-8.441908,"marketCap":49570266},{"date":"2025-11-07","current":-8.279302,"twenty":-22.041391,"median":-11.020085,"eighty":-8.422738,"marketCap":48851856},{"date":"2025-11-14","current":-7.974916,"twenty":-21.748538,"median":-10.626178,"eighty":-8.401057,"marketCap":47055832},{"date":"2025-11-21","current":-5.63932,"twenty":-21.591452,"median":-10.369584,"eighty":-8.291349,"marketCap":42844692},{"date":"2025-11-28","current":-5.550816,"twenty":-21.385059,"median":-10.251516,"eighty":-8.277237,"marketCap":42172284},{"date":"2025-12-05","current":-5.528159,"twenty":-21.145721,"median":-10.035835,"eighty":-8.205771,"marketCap":42000153},{"date":"2025-12-12","current":-5.346908,"twenty":-20.913783,"median":-9.622594,"eighty":-8.140964,"marketCap":40623098},{"date":"2025-12-19","current":-5.075032,"twenty":-20.676912,"median":-9.589382,"eighty":-8.091324,"marketCap":38557517},{"date":"2025-12-26","current":-4.984406,"twenty":-20.655198,"median":-9.504526,"eighty":-7.973859,"marketCap":37868990},{"date":"2026-01-02","current":-4.621904,"twenty":-20.64829,"median":-9.445491,"eighty":-7.844107,"marketCap":35114882},{"date":"2026-01-09","current":-4.667217,"twenty":-20.556996,"median":-9.386457,"eighty":-7.663288,"marketCap":35459145},{"date":"2026-01-16","current":-3.906415,"twenty":-20.052754,"median":-9.333317,"eighty":-7.532779,"marketCap":29678960},{"date":"2026-01-23","current":-4.236745,"twenty":-19.532624,"median":-9.295591,"eighty":-7.439743,"marketCap":32188641},{"date":"2026-01-30","current":-2.718767,"twenty":-19.137247,"median":-9.120856,"eighty":-7.230905,"marketCap":20655813},{"date":"2026-02-06","current":-2.789908,"twenty":-19.014048,"median":-9.091285,"eighty":-6.038299,"marketCap":21196306},{"date":"2026-02-13","current":-2.62361,"twenty":-18.829077,"median":-9.002734,"eighty":-5.643206,"marketCap":19932859},{"date":"2026-02-20","current":-2.523469,"twenty":-18.599351,"median":-8.973217,"eighty":-5.552986,"marketCap":19172037}],"updateTime":1771714116298},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"JUNS\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2613218169","title":"Jupiter Neurosciences Amends Yorkville Financing Agreement Terms","url":"https://stock-news.laohu8.com/highlight/detail?id=2613218169","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613218169?lang=en_us&edition=fundamental","pubTime":"2026-02-21 06:31","pubTimestamp":1771626676,"startTime":"0","endTime":"0","summary":"The latest update is out from Jupiter Neurosciences, Inc. ( ($JUNS) ). On February 20, 2026, Jupiter Neurosciences, Inc. amended the terms of its f...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/jupiter-neurosciences-amends-yorkville-financing-agreement-terms?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/jupiter-neurosciences-amends-yorkville-financing-agreement-terms?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","JUNS"],"gpt_icon":0},{"id":"2613290209","title":"Jupiter Neurosciences Amends Yorkville Convertible Notes to Delay Monthly Payments Until April 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2613290209","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613290209?lang=en_us&edition=fundamental","pubTime":"2026-02-21 06:09","pubTimestamp":1771625348,"startTime":"0","endTime":"0","summary":"Jupiter Neurosciences Inc. said it entered into an omnibus amendment on Feb. 20, 2026 with YA II PN, LTD  to modify the monthly payment terms of its amended and restated convertible promissory notes issued under a standby equity purchase agreement. The amendment delays the start of monthly installment payments to April 1, 2026, shifts payments to a variable schedule, and updates provisions governing advance notices, while allowing the company to satisfy installments in cash, via advance repayment, or a combination of both.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jupiter Neurosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system opera","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260220:nNDL5Y3qBm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JUNS","BK4007"],"gpt_icon":0},{"id":"2606790652","title":"Jupiter Neurosciences Inc - Announces Strategic Initiative for Glp-1 Users","url":"https://stock-news.laohu8.com/highlight/detail?id=2606790652","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606790652?lang=en_us&edition=fundamental","pubTime":"2026-01-28 19:00","pubTimestamp":1769598040,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260128:nFWN3YT0RT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["JUNS","BK4007"],"gpt_icon":0},{"id":"2606403790","title":"Jupiter Neurosciences Expands Nugevia™ Addressable Market with Focus on GLP-1 Users","url":"https://stock-news.laohu8.com/highlight/detail?id=2606403790","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606403790?lang=en_us&edition=fundamental","pubTime":"2026-01-28 19:00","pubTimestamp":1769598000,"startTime":"0","endTime":"0","summary":"Nugevia supports metabolic, mitochondrial, and neuroinflammatory biology impacted by GLP-1-driven weight loss Jupiter, Florida, Jan.  28, 2026  (GLOBE NEWSWIRE) -- Jupiter Neurosciences, Inc. (NASDAQ:","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/01/28/3227379/0/en/Jupiter-Neurosciences-Expands-Nugevia-Addressable-Market-with-Focus-on-GLP-1-Users.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GLP","BK4590","CNS","BK4144","JUNS","BK4135","BK4007"],"gpt_icon":0},{"id":"2606735178","title":"Jupiter Neurosciences to Present at DealFlow Discovery Conference in Atlantic City","url":"https://stock-news.laohu8.com/highlight/detail?id=2606735178","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606735178?lang=en_us&edition=fundamental","pubTime":"2026-01-27 23:45","pubTimestamp":1769528715,"startTime":"0","endTime":"0","summary":"Jupiter Neurosciences, Inc. will participate in the 3rd Annual DealFlow Discovery Conference, taking place January 28-29, 2026, at The Borgata Hotel, Casino & Spa in Atlantic City, NJ. Chairman and CEO Christer Rosén will deliver a company presentation and be available for one-on-one investor meetings throughout the event.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jupiter Neurosciences Inc. published the original content used to generate this news brief via ACCESS Newswire  on January 27, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260127:nNDL3p707L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","JUNS"],"gpt_icon":0},{"id":"2593446321","title":"Jupiter Neurosciences Secures $1.86 Million Second Tranche Financing from Yorkville","url":"https://stock-news.laohu8.com/highlight/detail?id=2593446321","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593446321?lang=en_us&edition=fundamental","pubTime":"2025-12-24 06:30","pubTimestamp":1766529009,"startTime":"0","endTime":"0","summary":"Jupiter Neurosciences Inc. has entered into a financing arrangement under a Standby Equity Purchase Agreement  with Yorkville. On December 23, 2025, the company received $1,860,000 as the second tranche of a pre-paid advance, following stockholder approval. In exchange, Jupiter issued a second convertible promissory note to Yorkville. The agreement allows Jupiter, at its discretion, to direct Yorkville to purchase additional shares of its common stock up to a defined maximum amount, subject to the terms of the SEPA. The securities are being issued in reliance on an exemption from registration under the Securities Act.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jupiter Neurosciences Inc. published the original content used to genera","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251223:nNDL6vzJF1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JUNS","BK4007"],"gpt_icon":0},{"id":"2593458718","title":"Jupiter Neurosciences Inc. Held Annual Shareholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2593458718","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593458718?lang=en_us&edition=fundamental","pubTime":"2025-12-23 05:31","pubTimestamp":1766439077,"startTime":"0","endTime":"0","summary":"Jupiter Neurosciences Inc. held its 2025 Annual Meeting of Stockholders on December 19, 2025. Stockholders approved the Jupiter Neurosciences Inc. 2025 Equity Incentive Plan and an amendment to the company's certificate of incorporation to increase the number of authorized shares of common stock from 125,000,000 to 500,000,000.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jupiter Neurosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 22, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251222:nNDL29Gq6Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","JUNS"],"gpt_icon":0},{"id":"2588066274","title":"Jupiter Neurosciences to Present at NobleCon21 Emerging Growth Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2588066274","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588066274?lang=en_us&edition=fundamental","pubTime":"2025-12-03 05:15","pubTimestamp":1764710158,"startTime":"0","endTime":"0","summary":"Jupiter Neurosciences Inc. will participate in the Noble Capital Markets' 21st Annual Emerging Growth Equity Conference  on December 2-3, 2025, in Boca Raton, Florida. The company's management team will present at the event and be available for one-on-one meetings with members of the investment community.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jupiter Neurosciences Inc. published the original content used to generate this news brief via Newsfile  on December 02, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251202:nNDL7tcx8W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JUNS","BK4007"],"gpt_icon":0},{"id":"2586930162","title":"BRIEF-Jupiter Neurosciences Files Rospectus Related To Resale Of Up To 10 Million Shares Of Our Common Stock By Selling Stockholder","url":"https://stock-news.laohu8.com/highlight/detail?id=2586930162","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586930162?lang=en_us&edition=fundamental","pubTime":"2025-11-27 06:32","pubTimestamp":1764196340,"startTime":"0","endTime":"0","summary":"BRIEF-Jupiter Neurosciences Files Rospectus Related To Resale Of Up To 10 Million Shares Of Our Common Stock By Selling StockholderNov 26  - Jupiter Neurosciences Inc JUNS.O:JUPITER NEUROSCIENCES INC - FILES ROSPECTUS RELATED TO RESALE OF UP TO 10 MILLION SHARES OF OUR COMMON STOCK BY SELLING STOCKHOLDERSource text: [ID:n0001493152-25-025204]Further company coverage: JUNS.O ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251126:nFWN3X20LZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JUNS","BK4007"],"gpt_icon":0},{"id":"2586036293","title":"Jupiter Neurosciences Inc - Files Rospectus Related to Resale of up to 10 Mln Shares of Our Common Stock by Selling Stockholder","url":"https://stock-news.laohu8.com/highlight/detail?id=2586036293","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586036293?lang=en_us&edition=fundamental","pubTime":"2025-11-27 06:30","pubTimestamp":1764196228,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251126:nFWN3X20LZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","JUNS"],"gpt_icon":0},{"id":"2585157743","title":"Jupiter Neurosciences Issues Amended SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2585157743","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585157743?lang=en_us&edition=fundamental","pubTime":"2025-11-21 05:06","pubTimestamp":1763672782,"startTime":"0","endTime":"0","summary":"Jupiter Neurosciences Inc. has filed an amendment to its previously issued Form 8-K report to update and correct information in Item 1.01. The amended report, filed on November 19, 2025, modifies details originally disclosed in the October 27, 2025 filing.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jupiter Neurosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 20, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251120:nNDL7wsBZZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","JUNS"],"gpt_icon":0},{"id":"2581706248","title":"Jupiter Neurosciences price target lowered to $25 from $30 at Greenridge","url":"https://stock-news.laohu8.com/highlight/detail?id=2581706248","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581706248?lang=en_us&edition=fundamental","pubTime":"2025-11-06 04:15","pubTimestamp":1762373754,"startTime":"0","endTime":"0","summary":"Greenridge analyst William Gregozeski lowered the firm’s price target on Jupiter Neurosciences (JUNS) to $25 from $30 and keeps a Buy rating on the...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/jupiter-neurosciences-price-target-lowered-to-25-from-30-at-greenridge-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/jupiter-neurosciences-price-target-lowered-to-25-from-30-at-greenridge-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["JUNS"],"gpt_icon":0},{"id":"2581247778","title":"Jupiter receives FDA clearance of IND application to initiate Phase 2 trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2581247778","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581247778?lang=en_us&edition=fundamental","pubTime":"2025-11-05 21:36","pubTimestamp":1762349790,"startTime":"0","endTime":"0","summary":"Jupiter Neurosciences (JUNS) announced that the U.S. Food and Drug Administration, FDA, has cleared its Investigational New Drug, IND, application ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/jupiter-receives-fda-clearance-of-ind-application-to-initiate-phase-2-trial-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/jupiter-receives-fda-clearance-of-ind-application-to-initiate-phase-2-trial-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","JUNS"],"gpt_icon":0},{"id":"2581778994","title":"BRIEF-Jupiter Neurosciences Receives FDA Clearance of IND Application to Initiate Phase 2a Clinical Trial of JOTROL in Parkinson’s Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2581778994","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581778994?lang=en_us&edition=fundamental","pubTime":"2025-11-05 21:32","pubTimestamp":1762349530,"startTime":"0","endTime":"0","summary":"BRIEF-Jupiter Neurosciences Receives FDA Clearance of IND Application to Initiate Phase 2a Clinical Trial of JOTROL in Parkinson’s DiseaseNov 5 (Reuters) - Jupiter Neurosciences Inc JUNS.O:JUPITER NEU","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251105:nTUA1CWBXN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","JUNS"],"gpt_icon":0},{"id":"2581077869","title":"Jupiter Neurosciences Inc - Expects Trial Enrollment to Begin in Early 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2581077869","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581077869?lang=en_us&edition=fundamental","pubTime":"2025-11-05 21:30","pubTimestamp":1762349400,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251105:nTUA1CWBXN:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","JUNS"],"gpt_icon":0},{"id":"2578646732","title":"Jupiter Neurosciences Inc - Proceeds to Support Phase 2 Parkinson's Trial and Nugevia Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2578646732","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578646732?lang=en_us&edition=fundamental","pubTime":"2025-10-27 20:30","pubTimestamp":1761568201,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251027:nTUA6ZR1PN:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["JUNS","BK4007"],"gpt_icon":0},{"id":"2578641221","title":"Jupiter Neurosciences Enters into Agreements for up to $20 Million in Flexible Financing","url":"https://stock-news.laohu8.com/highlight/detail?id=2578641221","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578641221?lang=en_us&edition=fundamental","pubTime":"2025-10-27 20:30","pubTimestamp":1761568200,"startTime":"0","endTime":"0","summary":"Financing designed to support Phase 2 Parkinson’s trial and accelerate Nugevia product line growth  Jupiter, FL, Oct.  27, 2025  (GLOBE NEWSWIRE) -- Jupiter Neurosciences, Inc (“JUNS” or the “Company”","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/27/3174574/0/en/Jupiter-Neurosciences-Enters-into-Agreements-for-up-to-20-Million-in-Flexible-Financing.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JUNS","BK4007"],"gpt_icon":0},{"id":"2576064012","title":"Jupiter Neurosciences Inc. Announces Date for Upcoming Annual Stockholders Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2576064012","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576064012?lang=en_us&edition=fundamental","pubTime":"2025-10-18 05:26","pubTimestamp":1760736387,"startTime":"0","endTime":"0","summary":"Jupiter Neurosciences, Inc. has announced that it will hold its 2025 Annual Meeting of Stockholders on December 12, 2025. The meeting will be conducted in a virtual format.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jupiter Neurosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on October 17, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251017:nNDL8jwz2c:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","JUNS"],"gpt_icon":0},{"id":"2567119063","title":"Jupiter Neurosciences Names Visionary Entrepreneur and Biohacker Jean Fallacara as Third Nugevia™ Brand Ambassador","url":"https://stock-news.laohu8.com/highlight/detail?id=2567119063","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567119063?lang=en_us&edition=fundamental","pubTime":"2025-09-15 20:00","pubTimestamp":1757937600,"startTime":"0","endTime":"0","summary":"Partnership strengthens Nugevia launch bringing clinical and scientific integrity to the fast-growing longevity space  Jupiter, Florida, Sept.  15, 2025  (GLOBE NEWSWIRE) -- Jupiter Neurosciences, Inc","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/09/15/3149961/0/en/Jupiter-Neurosciences-Names-Visionary-Entrepreneur-and-Biohacker-Jean-Fallacara-as-Third-Nugevia-Brand-Ambassador.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JUNS","BK4007","CNS","BK4135"],"gpt_icon":0},{"id":"2562736608","title":"Jupiter Neurosciences Launches Nugevia™ Website and Opens Pre-Orders for Groundbreaking Longevity Supplements","url":"https://stock-news.laohu8.com/highlight/detail?id=2562736608","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562736608?lang=en_us&edition=fundamental","pubTime":"2025-08-26 20:00","pubTimestamp":1756209600,"startTime":"0","endTime":"0","summary":"Targeting the Multi-Trillion Dollar Longevity Market Jupiter, Florida, Aug.  26, 2025  (GLOBE NEWSWIRE) -- Jupiter Neurosciences, Inc. (NASDAQ: JUNS) (“Jupiter” or the “Company”), a clinical-stage pha","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/08/26/3139219/0/en/Jupiter-Neurosciences-Launches-Nugevia-Website-and-Opens-Pre-Orders-for-Groundbreaking-Longevity-Supplements.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CNS","JUNS","BK4007","BK4135"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":20,"code":"91000000","status":"200"}]}}